DCE-MR imaging and ADC parameters

Recurrence (n = 25)
(Median [Range])
Benign Posttreatment Change
(n = 26) (Median [Range])
P Value
DCE parameters
 Vp0.09 (0.02–0.22)0.05 (0.01–0.14)
 Reference Vp0.01 (0.01–0.04)0.02 (0.01–0.05)
 nVp7.00 (0.50–17.33)2.02 (0.33–14.33).003a
 Ve0.39 (0.07–0.98)0.28 (0.01–1.08)
 Reference Ve0.14 (0.01–0.26)0.19 (0.07–0.67)
 nVe2.55 (0.32–97.66)1.56 (0.01–6.35).014
 Ktrans0.25 (0.06–1.02)0.13 (0.01–0.39)
 Reference Ktrans0.08 (0.01–0.15)0.11 (0.04–0.33)
 nKtrans3.87 (0.66–101.00)1.27 (0.03–8.00)<.001a
 Kep0.61 (0.39–2.03)0.50 (0.16–2.12)
 Reference Kep0.48 (0.02–1.36)0.55 (0.32–1.06)
 nKep1.45 (0.47–26.17)0.96 (0.28–2.69).009
 AUC28,265 (3523–427,571)11,887 (537–335,025)
 Reference AUC7119 (615–188,345)7890 (3530–185,938)
 nAUC3.34 (1.31–20.81)1.39 (0.01–9.96)<.001a
 WI1.03 (0.29–2102.33)0.70 (0.06–38.00)
 Reference WI0.38 (0.02–696.00)0.33 (0.07–21.24)
 nWI4.13 (0.99–20.17)1.70 (0.07–32.48)<.001a
 WO0.68 (0.01–472.33)0.57 (0.01–18.99)
 Reference WO0.08 (0.01–117.00)0.43 (0.02–27.28)
 nWO3.78 (0.31–292.88)1.35 (0–109.00).016
 ADC value1.01 (0.55–1.30)1.61 (1.02–2.53)
 Reference ADC0.79 (0.56–0.94)0.78 (0.67–0.99)
 nADCmean1.31 (0.77–1.65)2.07 (1.39–3.04)<.001a
  • a Statistically significant.